A team of UConn Health researchers has designed a novel, hybrid hydrogel system to help address some of the challenges in repairing bone in the event of injury. The UConn Health team, led by associate professor of orthopedic surgery Syam Nukavarapu, described their findings in a recent issue of Journal of Biomedical Materials Research-Part B.

There are over 200 bones in an adult human skeleton, ranging in size from a couple of millimeters in length to well over a foot. How these bones form and how they are repaired if injured varies, and has posed a challenge for many researchers in the field of regenerative medicine.

Two processes involved with human skeletal development help all the bones in our body form and grow. These processes are called intramembranous and endochondral ossification, IO, and EO respectively. While they are both critical, IO is the process responsible for the formation of flat bones, and EO is the process that forms long bones like femurs and humeri.

For both processes, generic mesenchymal stem cells (MSCs) are needed to trigger the growth of new bone. Despite this similarity, IO is significantly easier to recreate in the lab since MSCs can directly differentiate, or become specialized, into bone-forming cells without taking any additional steps.

Nukavarapu notes that vascularization is the key in segmental bone defect repair and regeneration. The main problem with IO-formed bone is caused by a lack of blood vessels, also called vascularization.

While IO's simplicity caused limitations, EO's benefits result in an intricate balancing act. EO requires precise spatial and temporal coordination of different elements, like cells, growth factors, and an extracellular matrix, or scaffold, onto which the MSCs attach, proliferate, and differentiate.

To achieve this delicate balance in the lab, Nukavarapu and his colleagues combined two materials known to encourage tissue regeneration – fibrin and hyaluronan – to create an effective extracellular matrix for long bone formation.

Fibrin gel mimics human bone mesenchymal stem cells and facilitates their condensation, which is required for MSC differentiation into chondrogenic cells. Hyaluronan, a naturally occurring biopolymer, mimics the later stages of the process by which differentiated chondrogenic cells grow and proliferate, also known as hypertrophic-chondrogenic differentiation.

The researchers anticipate that cartilage templates with hypertrophic chondrocytes will release bone and vessel forming factors and will also initiate vascularized bone formation. Nukavarapu says that the "use of cartilage-template matrices would lead to the development of novel bone repair strategies that do not involve harmful growth factors."

"Dr. Nukavarapu's work speaks not only to the preeminence of UConn's faculty but also to the potential real-world applications of their research," says Radenka Maric, vice president for research at UConn and UConn Health.

"UConn labs are buzzing with these types of innovations that contribute to scientific breakthroughs in healthcare, engineering, materials science, and many other fields."

The researchers next plan to integrate the hybrid extracellular matrix with a load-bearing scaffold to develop cartilage templates suitable for long-bone defect repair.

According to Nukavarapu, the UConn research team is hopeful that this is the first step towards forming a hypertrophic cartilage template with all the right ingredients to initiate bone tissue formation, vascularization, remodeling, and ultimately the establishment of functional bone marrow to repair long bone defects through EO.